Pfizer CEO: Tariff Uncertainty Hindering US Investment in Manufacturing and R&D

Pfizer CEO Albert Bourla remarked on Tuesday that uncertainties surrounding President Donald Trump’s Drug Tariff are hindering the company’s ability to pursue further investments in U.S. manufacturing and R&D.

During the company’s Q1 Revenue Call, Bourla responded to inquiries about Pfizer’s expectations regarding tariff negotiations, emphasizing the need for increased investments in the U.S.

“If there’s a guarantee of no tariffs… significant investments could be made in both R&D and manufacturing here,” Bourla stated, emphasizing the company’s desire for “certainty.”

“In times of uncertainty, everyone is focused on minimizing costs, as we are, leading to frugal investment practices. We are poised to allocate funds; that’s what I hope to see,” Bourla commented.

He highlighted that the current tax climate, which previously favored overseas manufacturing, is “undergoing significant changes” with the establishment of a global minimum tax around 15%. Bourla expressed concerns that these changes alone do not necessarily make the U.S. a more appealing investment destination without added tariff incentives or clarity.

“I spoke with [Trump], and I believe he aims to modify the existing tax framework, particularly for domestically produced goods,” Bourla said, indicating that further reductions could incentivize U.S. manufacturing.

In contrast to other companies navigating shifting trade policies, Pfizer did not alter its full-year forecast on Tuesday. Nevertheless, the company noted in a revenue statement that its guidance “currently does not account for any potential impacts related to future tariffs or trade policy changes, which remain unpredictable.”

In the revenue call, Pfizer executives mentioned that the guidance reflects $150 million in expenses attributed to Trump’s existing tariffs.

“The guidance we didn’t address today includes some of the current tariffs,” stated Pfizer CFO Dave Denton over the phone.

“We believe we are still trending towards the upper end of the guidance range, even with these costs this year,” he added.

Source: www.nbcnews.com

How Trump’s tariffs are hindering phone repair in the US

The tariffs implemented in the US overnight on Wednesday are expected to raise the prices of new smartphones. However, opting to repair an old or damaged device to save money may not necessarily result in a lower bill.

“Unfortunately, I anticipate having to increase my prices for parts,” explained Elizabeth Chamberlain, sustainability director at IFIXIT, a device repair company. “While we are actively seeking domestically-sourced parts, even with higher prices, repairs are still more cost-effective than purchasing new devices.”

Donald Trump’s tariffs could impact smartphone repair costs due to the global supply chain for device components. Many parts for popular Apple and Samsung mobile phones are manufactured outside the US. iPhones are primarily made in China, and companies exporting to the US face over 100% customs duties. India, where Apple and Google also have production facilities, is subject to a 26% tariff. Samsung’s supply chain is mainly in South Korea and could see a 25% tariff if agreements are not reached with the Trump administration.


The tariffs could drive up the demand for phone repairs as individual parts remain more affordable than buying new devices, even with higher prices. Customs duties could add nearly $300 to the price of the latest iPhone.

“It’s too early to determine if the tariff news is leading to increased repair demand, but it makes more sense than ever to repair what we have,” Chamberlain noted. “I believe tariffs could also stimulate demand for renovations and local parts sourcing in the repair industry.”

Increase in Parts Prices

Both large and small repair shops are bracing for higher prices for imported parts. A Brooklyn shop manager, who preferred not to be named, revealed that a national repair chain location is anticipating a 20% price hike for many necessary repair parts.

Dan Fernando, owner of Tecquecia, an independent repair shop in Philadelphia, has already seen fluctuations in prices for components like specific hard drives used for computer repairs. Fernando sources parts from a supplier called MobilesEntrix, which imports parts to the US.

“For phone screen replacements, we charge a $50 flat fee plus the screen cost,” Fernando explained. “Customers may now expect to pay between $80 and $90 for a screen replacement, with the new tariffs potentially resulting in a 50% increase.”

Fernando is also exploring cheaper repair options, stating, “Some people buy parts from eBay or Amazon which I don’t use due to quality concerns.”

Skip past newsletter promotions

The Attraction of Second-Hand Devices

With the rising costs of new devices and repairs, the second-hand device market, such as Swappa, offers a viable alternative for consumers. Swappa’s top-selling devices currently include the iPhone 13 and 14, according to Ben Edwards, the site’s founder.

“If tariffs persist and drive up new device prices further, I believe many buyers will turn to Swappa and similar platforms,” Edwards predicted. “The latest generation may not offer enough technical advantages to justify the increased costs.”

However, the prices of refurbished devices on Swappa could also rise as sellers adjust to the higher costs of new devices. Edwards explained that market dynamics determine prices on Swappa, with individual sellers setting their own prices.

“Ultimately, demand dictates prices,” Edwards highlighted. “In the Swappa marketplace, sellers have the freedom to set prices based on supply and demand.”

For consumers in the market for second-hand devices, Edwards advised, “Don’t wait.”

Source: www.theguardian.com

How health trackers may be hindering your journey to optimal health | Life & Style

ohOne thing after another happened, and I was lying shirtless on the couch, with a wrinkled nose as a cardiologist explained that everything was fine, but that my heart was a little… weird. I can’t remember the exact words, but it was probably just above “quirky,” but not quite weird. He was looking at something else entirely, and had noticed that the valves at the top of my heart were a little weird. It had absolutely nothing to do with why I’d come here, and was unlikely to affect my future health in any way, he said. But now that he’d seen it, he thought it best to tell me. I asked if it was good to know, and he shrugged. “Sometimes?” he said vaguely. “It’s complicated.”

At home, I paid more attention than usual to my heartbeat, listening for any unusual sounds. A few months later, when I experienced what turned out to be indigestion, I went to the doctor, worried that my valve was about to burst. I had no history of anxiety disorders and had never paid much attention to what was going on inside my body, thinking it was inevitably unfathomable, like anything going on in the vast depths of the ocean. But once this flaw was revealed, I became uncomfortably aware of every moving part, of everything that might go wrong.

When I read Caroline Crampton’s recent detailed study of hypochondria, A body made of glass aptly describes health anxiety disorder as “a bodily illness that exists only in the mind,” and my hand immediately went to my chest. From 18th-century quack medicine to today’s health industry, Crampton traces the rise of drugs and devices promising relief from imagined ailments, such as the Zeebo pill (currently £73 on Amazon), which is promoted as a placebo and “you yourself are the active ingredient,” and plans for technology that can observe every part of our minds and bodies. But, she asks, can we ever know too much? Reading recent criticisms of blood glucose monitoring and the rise of the Zoe app, I thought of Crampton’s book. These are part of a growing trend for personalized diets, but along with other criticisms (such as a lack of evidence about their effectiveness), Professor Partha Carr, the NHS’s national diabetes adviser, told the BBC that using a continuous glucose monitor (designed for diabetics) for no health reason can make people obsessed with the numbers and, in some cases, “can lead to eating disorders.”

These are apps for “worried people” – healthy people who worry about their health – a growing market at a time when new technology and the old internet are stoking anxiety by providing vast amounts of knowledge to anyone with Wi-Fi. It’s a successful business model, in that they’re both apps for anxious people and apps that create anxious people. Parents are especially susceptible to marketing, with health anxieties projected onto their children. This month’s New YorkerJia Tolentino detailed her efforts to hide her pregnancy from her phone, which meant not buying baby clothes online, not using a period tracker, and not using pregnancy apps. She wanted to avoid being watched, which can be especially hard when you’re encouraged to watch yourself.

In the time it took me to give birth to my two children, there had been an explosion in the technology offered to parents who wanted to both track their pregnancies (through additional ultrasound scans, for example) and keep an eye on their babies (with devices like stuffed toys with hidden cameras or disks that attach to diapers that alert you when your baby rolls over). By 2020, I was surprised at how hard it was to buy, for example, a baby monitor that didn’t include a camera, didn’t require a Wi-Fi connection, and didn’t capture any data. And yet, despite the desire for parenting technology, Tolentino found that it rarely led to better outcomes for babies, but rather exacerbated or, worse, created the anxieties that led to the purchase of these devices. The control that anxious people seek by monitoring their babies and their bodies is an illusion.

This is disturbing, given the growing number of products targeted directly at them. The global wearable technology market (fitness trackers and other devices) is expected to be valued at $61.3 billion in 2022, and to expand significantly by 2030. My 9-year-old’s school friends regularly compare FitBits. But for some, trackers and the like may be doing more harm than good. New Statesman In 2019, a professor of cardiovascular medicine criticized a large study of atrial fibrillation (a common heart rhythm problem) in Apple Watch owners, saying there was no significant health benefit to testing low-risk people, “the kind of people who wear Apple Watches,” and that the study would “inflict substantial distress” on healthy people who would receive notifications about their irregular heartbeat.

Health anxieties have evolved alongside scientific knowledge, with phrases like “cyberchondria” (anxiety heightened by information found online) emerging and some research suggesting that our new loose connection to medical knowledge is making people more anxious rather than lessening it. I resent the way tech companies prey on these anxieties, creating new concerns for profit. I believe it’s true that we can know too much.

Every now and then, a small pain or memory in my chest will raise a chill and I’ll think about my deformed heart, but in those moments I will tell myself sternly that it’s none of my business what’s going on under the sea, or deep inside my body (as long as it doesn’t affect my life).

Email Eva at e.wiseman@observer.co.uk or follow her on X. Eva Wise man

Source: www.theguardian.com